Global Oligonucleotide Synthesis Market Forecast to Reach $2.46 Billion by 2022 - Product, Application and End-User Analysis

DUBLIN, April 13, 2018 /PRNewswire/ --

The "Oligonucleotide Synthesis Market by Product (Primer, Probe, Linker, Adaptor, Custom, Reagent, Equipment), Application (PCR, DNA, RNAi, Research, Therapeutic), End User (Academic, Pharmaceutical, Biotechnology) - Global Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.

The global oligonucleotide synthesis market is expected to reach USD 2.46 billion by 2022 from USD 1.47 billion in 2017 at a CAGR of 10.9%.

Growth in this market is mainly driven the increasing R&D expenditure by pharmaceutical and biotechnology companies, rising demand for synthesized oligonucleotides from the growing field of molecular diagnostics, rising venture capital investments, and increasing demand for synthetic genes. However, the price erosion of synthesized oligos and lack of regulations for therapeutic oligos are some factors that may hinder the growth of this market.

Based on product, the market is segmented into synthesized oligonucleotides, reagents, and equipment. The synthesized oligonucleotides segment is expected to grow at the highest CAGR during the forecast period The increasing number of applications of synthesized oligonucleotides in research, diagnostics, and therapeutics is a key market driver in this segment. The rising availability and demand for custom oligos also contribute to the growth of the synthesized oligonucleotides market.

Based on application, the market is segmented into research, diagnostics, and therapeutics. The research segment is estimated to hold the largest share of the oligonucleotide synthesis market in 2017. The market growth for research applications is mainly driven by the developments in the fields of gene synthesis and NGS. Oligos are widely used in technologies such as PCR, qPCR, gene synthesis, isothermal nucleic acid amplification technology (INAAT), microarray, hybridization, DNA sequencing, and next-generation sequencing (NGS).

Based on end user, the market is segmented into academic research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and other end users. The academic research institutes segment is expected to dominate the market during the forecast period. With the increasing funding pouring into institutes to conduct research, the demand for oligonucleotides is bound to increase. To meet this need, companies are launching products and entering into agreements with different research institutes to supply oligonucleotides for research purposes. For instance, in August 2015, Eurofins Genomics launched NGS tests for the identification of non-targeted microorganisms, including 16S Microbiome Profiling for academia and research.

In 2017, North America is expected to account for the largest share of the market followed by Europe. However, Asia Pacific is expected to register the highest CAGR during the forecast period. This can be attributed to factors such as the growing availability of synthesized oligos, along with an increase in R&D funding and activities in the APAC region. The increasing focus of prominent players on APAC is also supporting market growth in the region.

Key Topics Covered

1 Introduction
1.1 Objectives of the Study
1.2 Definition
1.3 Market Scope
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.2 Secondary Data
2.3 Primary Data
2.4 Market Size Estimation
2.5 Market Breakdown and Data Triangulation
2.6 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Attractive Opportunities in Oligonucleotide Synthesis Market
4.2 Oligonucleotides Synthesis Market, By Synthesized Oligonucleotides Products
4.3 Market, By Synthesized Oligonucleotides Type
4.4 Europe: Market, By Research Application and Country
4.5 Oligonucleotide Synthesis Market, By Therapeutic Application
4.6 Market, By End User
4.7 Geographic Snapshot: Market

5 Market Overview
5.1 Introduction
5.2 Market Drivers
5.3 Market Restraints
5.4 Market Opportunities
5.5 Market Challenges
5.6 Industry Trends

6 Oligonucleotide Synthesis Market, By Product
6.1 Introduction
6.2 Synthesized Oligonucleotides
6.3 Reagents
6.4 Equipment

7 Oligonucleotide Synthesis Market, By Application
7.1 Introduction
7.2 Research
7.3 Diagnostics
7.4 Therapeutics

8 Oligonucleotide Synthesis Market, By End User
8.1 Introduction
8.2 Academic Research Institutes
8.3 Pharmaceutical and Biotechnology Companies
8.4 Diagnostic Laboratories
8.5 Other End Users

9 Oligonucleotide Synthesis Market, By Region
9.1 Introduction
9.2 North America
9.3 Europe
9.4 Asia Pacific (APAC)
9.5 Latin America
9.6 Middle East & Africa

10 Competitive Landscape
10.1 Overview
10.2 Market Share Analysis
10.3 Competitive Scenario

11 Company Profiles
11.1 Integrated DNA Technologies
11.2 Merck KGaA
11.3 Eurofins Genomics
11.4 Thermo Fisher Scientific
11.5 Bioautomation
11.6 Agilent Technologies
11.7 Eurogentec
11.8 GE Healthcare
11.9 LGC Biosearch Technologies
11.10 Nitto Denko Avecia
11.11 Genscript
11.12 Genedesign (Part of Ajinomoto)
11.13 TriLink Biotechnologies (Part of Maravai Lifesciences)
11.14 Bio-Synthesis
11.15 ATDBio

For more information about this report visit https://www.researchandmarkets.com/research/pkpg56/global?w=5

Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-oligonucleotide-synthesis-market-forecast-to-reach-2-46-billion-by-2022---product-application-and-end-user-analysis-300629515.html

SOURCE Research and Markets